| Trial ID: | L5356 |
| Source ID: | NCT01479075
|
| Associated Drug: |
Intransal Insulin
|
| Title: |
The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
|
| Acronym: |
Centrin
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes
|
| Interventions: |
DRUG: intransal insulin|DRUG: Placebo|DEVICE: taVNS|DEVICE: sham stimulation
|
| Outcome Measures: |
Primary: Insulin sensitivity, Assessment of insulin sensitivity with gold standard methods, 6 months | Secondary: Energy metabolism, Energy metabolism is assessed from gold standard methods, 6 months
|
| Sponsor/Collaborators: |
Sponsor: German Diabetes Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2011-08
|
| Completion Date: |
2014-06
|
| Results First Posted: |
|
| Last Update Posted: |
2023-06-05
|
| Locations: |
German Diabetic Center, Düsseldorf, Nordrhein- Westfalen, 40225, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT01479075
|
